Romanian Society of Pharmaceutical Sciences

Peer-review Process

Farmacia engages a strict peer-review process with at least two independent reviewers, followed by a final acceptance/rejection decision. The Editor-in-Chief is responsible for the academic quality of the publication process, including acceptance decisions.
After the submission of a manuscript, the managing editors assess the compatibility of the article’s topics with the Aims and Scope of Farmacia, the overall quality of the manuscript and plagiarism. Articles that do not fit the scientific purposes of Farmacia/ are of poor quality/submitted to plagiarism are rejected.
The peer-review process is single-blind, meaning that the author does not know the identity of the reviewer, but the reviewer knows the identity of the author.
At least two review reports are collected for each submitted article. The reviewers are selected among the Editorial Scientific Board, qualified reviewers from our database, or new reviewers identified by web searches for related articles. They should not have any conflict of interest with the authors and they must have scientific expertise for the manuscript’s subject.
Reviewers are given 14 days to write their review.
Acceptance decisions on manuscripts, after peer review, are made by the Editorial Board members based on the concordance between the reviewer’s comments and authors’ revisions of the manuscript and their proper responses.
The following selections can be made: accept, reject, minor revision, major revision.
Reviewers make recommendations, and the Editor-in-Chief may be discordant with their opinions. If so, there should be an accurate justification, for the benefit of the authors.
Editorial independence is extremely important and no member of the Editorial Board influences in any way the reviewers scientific opinions on the manuscripts.
The Editorial Board members are not involved in the processing their own academic work. Their submissions are assigned to at least two independent outside reviewers. Decisions are made by other editorial board members who do not have a conflict of interest with the author.